PUBLISHER: KBV Research | PRODUCT CODE: 1472514
PUBLISHER: KBV Research | PRODUCT CODE: 1472514
LAMEA Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Country and Growth Forecast, 2024 - 2031
The Latin America, Middle East and Africa Inhalation Capsules Market would witness market growth of 7.8% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $36.4 Million by 2031. The Argentina market is showcasing a CAGR of 8.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 7.4% during (2024 - 2031).
The focus on respiratory health and disease management is a significant catalyst for the growth of the inhalation capsules market by driving awareness, improving treatment outcomes, and fostering innovation in inhalation therapy. As respiratory diseases pose significant health challenges, the demand for effective and patient-friendly treatment options delivered via inhalation capsules will remain robust.
Additionally, one of the primary drivers behind the growth of the inhalation capsules market is the continuous innovation in inhalation device technologies. Manufacturers are developing advanced DPIs with improved drug delivery efficiency, dose accuracy, and patient convenience. These innovations include integrating smart features such as dose counters, feedback mechanisms, and connectivity options, allowing for better medication adherence and monitoring. Developing novel formulations and combination therapies delivered via inhalation capsules further expands the therapeutic options available to patients, driving market growth.
In the LAMEA region, the demand for inhalation capsules is rising, driven by various factors unique to each country. Brazil, for instance, boasts the largest healthcare sector in Latin America, allocating a significant portion of its GDP, around 9.47% or US$161 billion, to healthcare. Hence, the evolving healthcare landscape drives the rising demand for inhalation capsules in the LAMEA region.
Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Cipla Limited
- Novartis AG
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Lonza Group Ltd. (Capsugel)
- Chiesi Farmaceutici S.p.A
- Vectura Group Plc (Philip Morris International, Inc.)
- Elpen S.A.
- Healthcaps India Ltd.
- Qualicaps Co., LTD. (Roquette Freres SA)
LAMEA Inhalation Capsules Market Report Segmentation
By Type
- Gelatin Capsules
- Hypromellose Capsules
By Application
- Asthma Treatment
- COPD Management
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1LAMEA Inhalation Capsules Market, by Type
- 1.4.2LAMEA Inhalation Capsules Market, by Application
- 1.4.3LAMEA Inhalation Capsules Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market
Chapter 5.LAMEA Inhalation Capsules Market by Type
- 5.1LAMEA Gelatin Capsules Market by Country
- 5.2LAMEA Hypromellose Capsules Market by Country
Chapter 6.LAMEA Inhalation Capsules Market by Application
- 6.1LAMEA Asthma Treatment Market by Country
- 6.2LAMEA COPD Management Market by Country
- 6.3LAMEA Others Market by Country
Chapter 7.LAMEA Inhalation Capsules Market by Country
- 7.1Brazil Inhalation Capsules Market
- 7.1.1Brazil Inhalation Capsules Market by Type
- 7.1.2Brazil Inhalation Capsules Market by Application
- 7.2Argentina Inhalation Capsules Market
- 7.2.1Argentina Inhalation Capsules Market by Type
- 7.2.2Argentina Inhalation Capsules Market by Application
- 7.3UAE Inhalation Capsules Market
- 7.3.1UAE Inhalation Capsules Market by Type
- 7.3.2UAE Inhalation Capsules Market by Application
- 7.4Saudi Arabia Inhalation Capsules Market
- 7.4.1Saudi Arabia Inhalation Capsules Market by Type
- 7.4.2Saudi Arabia Inhalation Capsules Market by Application
- 7.5South Africa Inhalation Capsules Market
- 7.5.1South Africa Inhalation Capsules Market by Type
- 7.5.2South Africa Inhalation Capsules Market by Application
- 7.6Nigeria Inhalation Capsules Market
- 7.6.1Nigeria Inhalation Capsules Market by Type
- 7.6.2Nigeria Inhalation Capsules Market by Application
- 7.7Rest of LAMEA Inhalation Capsules Market
- 7.7.1Rest of LAMEA Inhalation Capsules Market by Type
- 7.7.2Rest of LAMEA Inhalation Capsules Market by Application
Chapter 8.Company Profiles
- 8.1Cipla Limited
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
- 8.2Novartis AG
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
- 8.2.5.1Trials and Approvals:
- 8.2.6SWOT Analysis
- 8.3AstraZeneca PLC
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
- 8.3.5.1Partnerships, Collaborations, and Agreements:
- 8.3.5.2Trials and Approvals:
- 8.3.6SWOT Analysis
- 8.4Boehringer Ingelheim International GmbH
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional & Segmental Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
- 8.5Lonza Group Ltd. (Capsugel)
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
- 8.6Chiesi Farmaceutici S.p.A
- 8.6.1Company Overview
- 8.6.2Recent strategies and developments:
- 8.6.2.1Partnerships, Collaborations, and Agreements:
- 8.6.2.2Product Launches and Product Expansions:
- 8.6.3SWOT Analysis
- 8.7Vectura Group plc (Philip Morris International, Inc.)
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
- 8.7.5.1Partnerships, Collaborations, and Agreements:
- 8.7.5.2Geographical Expansions:
- 8.7.6SWOT Analysis
- 8.8Elpen S.A.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
- 8.9Healthcaps India Ltd.
- 8.9.1Company Overview
- 8.9.2SWOT Analysis
- 8.10.Qualicaps Co., LTD. (Roquette Freres SA)
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 2LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 3LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 4LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 5LAMEA Gelatin Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 6LAMEA Gelatin Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 7LAMEA Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 8LAMEA Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 9LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 10LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 11LAMEA Asthma Treatment Market by Country, 2020 - 2023, USD Million
- TABLE 12LAMEA Asthma Treatment Market by Country, 2024 - 2031, USD Million
- TABLE 13LAMEA COPD Management Market by Country, 2020 - 2023, USD Million
- TABLE 14LAMEA COPD Management Market by Country, 2024 - 2031, USD Million
- TABLE 15LAMEA Others Market by Country, 2020 - 2023, USD Million
- TABLE 16LAMEA Others Market by Country, 2024 - 2031, USD Million
- TABLE 17LAMEA Inhalation Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 18LAMEA Inhalation Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 19Brazil Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 20Brazil Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 21Brazil Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 22Brazil Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 23Brazil Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 24Brazil Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 25Argentina Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 26Argentina Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 27Argentina Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 28Argentina Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 29Argentina Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 30Argentina Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 31UAE Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 32UAE Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 33UAE Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 34UAE Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 35UAE Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 36UAE Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 37Saudi Arabia Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 38Saudi Arabia Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 39Saudi Arabia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 40Saudi Arabia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 41Saudi Arabia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 42Saudi Arabia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 43South Africa Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 44South Africa Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 45South Africa Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 46South Africa Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 47South Africa Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 48South Africa Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 49Nigeria Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 50Nigeria Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 51Nigeria Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 52Nigeria Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 53Nigeria Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 54Nigeria Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 55Rest of LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 56Rest of LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 57Rest of LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 58Rest of LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 59Rest of LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 60Rest of LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 61Key Information - Cipla Limited
- TABLE 62Key Information - Novartis AG
- TABLE 63Key Information - AstraZeneca PLC
- TABLE 64Key Information - Boehringer Ingelheim International GmbH
- TABLE 65Key Information -Lonza Group Ltd.
- TABLE 66Key Information - Chiesi Farmaceutici S.p.A
- TABLE 67Key Information - Vectura Group plc
- TABLE 68Key Information - Elpen S.A.
- TABLE 69Key Information - Healthcaps India Ltd.
- TABLE 70Key Information - Qualicaps Co., LTD.
